ATG12 Protein is a protein involved in key cellular signaling pathways relevant to neurodegenerative diseases. This page provides comprehensive information about its structure, normal biological function, and role in disease pathogenesis.
ATG12 Protein participates in critical cellular processes that, when dysregulated, contribute to neurodegeneration. Understanding this protein's function is essential for developing therapeutic interventions for Alzheimer's disease, Parkinson's disease, and related conditions.
| ATG12 Protein | |
|---|---|
| Protein Name | ATG12 |
| Gene | [ATG12](/genes/atg12) |
| UniProt ID | O95168 |
| PDB Structure | 2DYO, 4TQ0, 5W6V |
| Molecular Weight | 14 kDa (ubiquitin-like protein) |
| Subcellular Localization | Cytoplasm (autophagosome formation sites) |
| Protein Family | ATG family (ubiquitin-like protein) |
ATG12 is a ubiquitin-like protein with a characteristic ubiquitin fold. It has a C-terminal glycine residue exposed after processing, which is used for thioester bond formation with ATG7 (E1) and ATG10 (E2), and finally conjugated to ATG5. ATG12 forms a stable conjugate with ATG5.
ATG12 is a ubiquitin-like protein essential for autophagosome formation. It is activated by ATG7 (E1 enzyme), transferred to ATG10 (E2 enzyme), and conjugated to ATG5, forming the ATG12-ATG5 complex. This complex functions as an E3 ligase, promoting LC3 lipidation and autophagosome closure. The ATG12-ATG5 conjugate also regulates apoptosis and mitochondrial metabolism.
ATG12 is essential for autophagy and neuronal survival. Disrupted autophagy is a hallmark of neurodegenerative diseases. ATG12 expression and function are altered in AD and PD, contributing to accumulation of protein aggregates. ATG12-mediated pathways are potential therapeutic targets.
ATG12 pathway activators could enhance autophagy in neurodegeneration. However, directly targeting ATG12 is challenging. Upstream activators of autophagy (mTOR inhibitors, AMPK activators) can enhance ATG12-mediated processes.